Clover Health Investments, Corp. vs Absci Corporation
ABSI wins the Tale of the Tape 4–3.
🏆 Tale of the Tape
Green = winner in each category. Higher is better except P/E (lower = cheaper).
Rolling Correlation
Low correlation — excellent diversification pair.
Fundamentals
| Metric | CLOV | ABSI |
|---|---|---|
| Market Cap | $2.4B | $1.4B |
| P/E Ratio | — | — |
| Forward P/E | 46.2x | -13.3x |
| P/B | 7.15x | 7.49x |
| Dividend Yield | — | — |
| Beta | 2.42 | 2.33 |
Quantitative Metrics
| Metric | CLOV | ABSI |
|---|---|---|
| DCF Fair Value | — | — |
| DCF Upside | — | — |
| Piotroski F | 2/9 | 2/9 |
| Altman Z | — | 5.11 |
| Beneish M | -1.81 | — |
| FCF Yield | — | -21.57% |
| Net Debt/EBITDA | — | — |
| ROIC | -20.3% | -46.9% |
| WACC | — | — |
| ROIC – WACC | — | — |
| Gross Margin | 18.5% | — |
| Net Margin | -4.5% | -4113.7% |
| Rev Growth YoY | 40.3% | -38.2% |
| Sharpe (1Y) | — | 0.56 |
| Max Drawdown 3Y | — | -66.1% |
| FCF Payout Ratio | — | — |
CLOV Price
ABSI Price
ETF Exposure
More Comparisons
Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.
CLOV vs ABSI: Head-to-Head Analysis
Clover Health Investments, Corp. (CLOV) and Absci Corporation (ABSI) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABSI leads 4–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.
In terms of capital efficiency, CLOV generates a return on invested capital (ROIC) of -20.3% compared to ABSI's -46.9%. This suggests CLOV is more effective at deploying capital to generate shareholder returns.
The 252-day rolling correlation between CLOV and ABSI is 0.245, indicating low correlation, making them an effective diversification pair in a portfolio context.
CLOV appears in 2 ETFs tracked by SecuritiesDB, while ABSI appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.
Frequently Asked Questions
Which stock is the better investment, CLOV or ABSI?
Our quantitative analysis compares CLOV and ABSI across nine fundamental dimensions. ABSI wins the Tale of the Tape 4–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.
Are CLOV and ABSI correlated?
The 252-day correlation between CLOV and ABSI is 0.245. They have low correlation, offering good diversification.
How is the Tale of the Tape scored?
The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.